NCT03875950

Brief Summary

The goal of this study is to facilitate uptake of and adherence to HIV pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) in Kenya. The investigators will conduct a cluster randomized controlled trial at 24 health facilities in Kisumu, Kenya of a clinical training intervention using standardized patient actors. The hypothesis is that the training will improve quality of PrEP service delivery, defined as adherence to national guidelines and non-judgmental communication.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
232

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2019

Completed
15 days until next milestone

Study Start

First participant enrolled

March 2, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 15, 2019

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2021

Completed
10 months until next milestone

Results Posted

Study results publicly available

October 12, 2022

Completed
Last Updated

October 12, 2022

Status Verified

October 1, 2022

Enrollment Period

2.3 years

First QC Date

February 15, 2019

Results QC Date

July 21, 2022

Last Update Submit

October 7, 2022

Conditions

Keywords

AdolescentsYoung womenHIV care and treatmentClinical trainingAfricaKenya

Outcome Measures

Primary Outcomes (1)

  • Quality of PrEP Counseling Provided by Health Care Workers Delivering PrEP to Adolescent Girls and Young Women for HIV Prevention in Kenya

    Quality is assessed as total score from a checklist provided by the SPs after each unannounced visit (n=71 SP visits in each arm) including domains of communication skills and adherence to national guidelines. Communication quality is assessed in an adapted version of the Bayer-Fetzer Kalamazoo Consensus Statement; scores range from 7-28 with higher scores indicating higher quality communication. Guideline adherence is assessed in a scoring system adapted from the Kenyan National AIDS \& STI Control Programme guidelines; scores range from 0-13 with higher scores indicating higher PrEP competency. Each measure is computed as a percent of total score possible. The total quality score will be a combined continuous score and rescaled out of 100 per unannounced SP visit. Mean scores among all SP encounters taking place in facilities randomized to the clinical intervention will be compared to mean scores among those randomized to standard of care.

    Unannounced standardized patient actor visits take approximately 15 minutes each, taking place over 3-4 months.

Secondary Outcomes (1)

  • Competency Score Measuring Quality of PrEP Counseling Provided by Health Care Workers During Clinical Training Intervention [Among Intervention Arm Only]

    Standardized patient actor training interactions take approximately 15 minutes each and will occur during a two-day training intervention. Trainings will be conducted over a period of 2-3 months.

Study Arms (2)

Training intervention

EXPERIMENTAL

In this cluster randomized control trial design, the experimental arm refers to the 12 study sites that are randomly assigned to receive the clinician training intervention. The intervention is a clinician training using standardized patient actors to improve communication and empathy skills of health care workers who deliver PrEP to adolescent girls and young women to prevent HIV.

Behavioral: Clinician training intervention

Standard of care control

NO INTERVENTION

In this randomized cluster randomized control trial design, the no intervention arm refers to the 12 study sites that are randomly assigned not to receive the clinician training intervention. Instead, these study sites will receive the standard of care, which is no standardized patient actor training, for health care workers who deliver PrEP to adolescent girls and young women to prevent HIV.

Interventions

This intervention is a clinician training using standardized patient actors to improve communication and empathy skills of health care workers delivering PrEP to adolescent girls and young women to prevent HIV in Kenya.

Training intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Facilities:
  • Facilities located in a county in Western Kenya
  • Currently offering PrEP services to adolescent girls and young women
  • Health care workers:
  • Age 18 or older
  • Current employee of one of the 24 study sites
  • Able to provide consent

You may not qualify if:

  • Facilities:
  • Health facilities where PrEP services are staffed by contract workers, program, or study staff
  • Health care workers:
  • Study staff seconded to the site as part of a trial or intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kenyatta National Hospital

Nairobi, Kenya

Location

Related Publications (1)

  • Larsen A, Wilson KS, Kinuthia J, John-Stewart G, Richardson BA, Pintye J, Abuna F, Lagat H, Owens T, Kohler P. Standardised patient encounters to improve quality of counselling for pre-exposure prophylaxis (PrEP) in adolescent girls and young women (AGYW) in Kenya: study protocol of a cluster randomised controlled trial. BMJ Open. 2020 Jun 21;10(6):e035689. doi: 10.1136/bmjopen-2019-035689.

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Limitations and Caveats

Intervention roll-out was delayed during the COVID-19 pandemic.

Results Point of Contact

Title
Pamela Kohler
Organization
University of Washington

Study Officials

  • Pamela K Kohler, RN, MPH, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, School of Nursing: Department Of Psychosocial And Community Health

Study Record Dates

First Submitted

February 15, 2019

First Posted

March 15, 2019

Study Start

March 2, 2019

Primary Completion

June 30, 2021

Study Completion

December 2, 2021

Last Updated

October 12, 2022

Results First Posted

October 12, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will share

The study investigators are prepared to share data with other researchers in accordance with NIH policies and other local regulations.

Shared Documents
STUDY PROTOCOL
Time Frame
Summary data may be shared or otherwise made available to interested parties starting 6 months after publication of trial results
Access Criteria
Access to data will be determined on a case-by-base basis in agreement with the Kenyan Ministry of Health. De-identified data will be made available for secondary analyses. Any data sharing will be performed through secure servers and/or encrypted external drives.

Locations